Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBD
Clinical trial NCT03671772 · COMPLETED
Trial details
- NCT number
- NCT03671772
- Sponsor
- Chinese University of Hong Kong
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-27
- Primary completion
- 2020-04-27
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.